贝雷帽
发表于 2025-3-26 22:58:38
http://reply.papertrans.cn/27/2682/268150/268150_31.png
生意行为
发表于 2025-3-27 04:00:38
Topical Vehicle Selection: Myths and Reality,risk of not engaging the target. Indeed to increase comfort that the target will be engaged one need to try fullfill as best as it can evidence of (1) sufficient compound on board for a desired time (i.e., PK within skin) and (2) demonstration of pharmacological activity .
Endoscope
发表于 2025-3-27 05:54:26
http://reply.papertrans.cn/27/2682/268150/268150_33.png
放逐某人
发表于 2025-3-27 11:18:08
http://reply.papertrans.cn/27/2682/268150/268150_34.png
Cabinet
发表于 2025-3-27 14:51:09
http://reply.papertrans.cn/27/2682/268150/268150_35.png
Antioxidant
发表于 2025-3-27 20:37:00
http://reply.papertrans.cn/27/2682/268150/268150_36.png
HEPA-filter
发表于 2025-3-27 22:09:49
http://reply.papertrans.cn/27/2682/268150/268150_37.png
Aura231
发表于 2025-3-28 05:40:49
http://reply.papertrans.cn/27/2682/268150/268150_38.png
arthroplasty
发表于 2025-3-28 06:34:01
Modern Voluntarist Views of Faithhe molecular basis of diseases as well as the push from payors to deliver better medicines compared to standard of care. This presents a strong opportunity for pharma companies who want to invest into dermal drug development projects as more assets and more therapeutic targets are becoming available
MUTE
发表于 2025-3-28 10:24:29
https://doi.org/10.1007/978-1-349-19036-2otations and rules are listed in this chapter. Extra comments met during the course of various topical drug development programs are added too. Overall these quotations and rules, sometimes considered provocative, may be found helpful for program teams developing a topical molecule.